Predictive Value of [18F]FDG PET/CT for Neoadjuvant Chemoradiotherapy Response in Nasopharyngeal Carcinoma
Journal of Clinical Medicine · 16.09.2025 · 14 (18) · 6508
DOI: 10.3390/jcm14186508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 16.09.2025. Verfasst von Natale Quartuccio und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Unit, Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Nasopharyngeal carcinoma (NPC) is a distinct malignancy of the head and neck with high prevalence in endemic regions and a strong association with Epstein–Barr virus (EBV). In locally advanced stages, neoadjuvant chemotherapy (NAC) followed by chemoradiotherapy improves outcomes, but response rates vary. Identifying early predictors of NAC response is essential for guiding personalized treatment strategies. This study aims to assess whether baseline [18F]FDG PET/CT parameters can predict NAC response in NPC patients.
Methods
In this retrospective study, 27 patients with histologically confirmed, locally advanced (stage III) NPC underwent baseline [18F]FDG PET/CT prior to NAC between 2015 and 2023. Quantitative PET parameters including SUVmax, SUVmean, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were extracted from the primary tumor. NAC response was assessed using RECIST 1.1 criteria and classified as responders (CR + PR) or non-responders (SD + PD). Group comparisons were performed using Student’s t-test. ROC analysis was used to identify optimal cut-off values. A p-value < 0.05 was considered significant.
Results
The cohort included 20 males and 7 females (mean age: 60.8 ± 15.2 years). The predominant histotype was undifferentiated non-keratinizing carcinoma (92.6%). A total of 19 patients (70.4%) responded to NAC. Responders had significantly lower baseline SUVmax (10.9 ± 4.8 vs. 15.8 ± 4.1, p = 0.021), MTV (16.2 ± 12.4 vs. 27.8 ± 19.5 cm3, p = 0.045), and TLG (128.6 ± 98.2 vs. 218.7 ± 152.4, p = 0.038). SUVmean was also lower in responders (6.1 ± 2.1 vs. 9.3 ± 2.8), although not statistically reported. ROC analysis identified SUVmax > 12.5 and MTV > 20.0 cm3 as thresholds associated with poor NAC response.
Conclusions
Baseline metabolic parameters from [18F]FDG PET/CT, particularly SUVmax and MTV, may assist stratification of NAC response in nasopharyngeal carcinoma. These biomarkers may facilitate pre-treatment stratification and guide more personalized therapeutic approaches. However, the limited sample size may affect the generalizability of these findings, and larger prospective studies are needed to confirm the results.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nuclear Medicine Unit, Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy.
- Otorhinolaryngology Section, Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C), University of Palermo, 90133 Palermo, Italy.
ORCID-Profile: Natale Quartuccio, Salvatore Ialuna
Zitieren
APA
Quartuccio, N., Sireci, F., Pulizzi, S., Nicolosi, S., D'Oppido, D., & Ialuna, S. (2025). Predictive Value of [18F]FDG PET/CT for Neoadjuvant Chemoradiotherapy Response in Nasopharyngeal Carcinoma. Journal of Clinical Medicine, 14(18), 6508. https://doi.org/10.3390/jcm14186508
Vancouver
Quartuccio N, Sireci F, Pulizzi S, Nicolosi S, D'Oppido D, Ialuna S. Predictive Value of [18F]FDG PET/CT for Neoadjuvant Chemoradiotherapy Response in Nasopharyngeal Carcinoma. Journal of Clinical Medicine. 2025;14(18):6508. doi:10.3390/jcm14186508
BibTeX
@article{Quartuccio2025,
author = {Quartuccio, Natale and Sireci, Federico and Pulizzi, Sabina and Nicolosi, Stefania and D'Oppido, Dante and Ialuna, Salvatore},
title = {Predictive Value of [18F]FDG PET/CT for Neoadjuvant Chemoradiotherapy Response in Nasopharyngeal Carcinoma},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {18},
pages = {6508},
doi = {10.3390/jcm14186508}
}
EUVIMED